U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C33H30N4O2
Molecular Weight 514.6169
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TELMISARTAN

SMILES

CCCC1=NC2=C(C)C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(O)=O)C5=NC6=C(C=CC=C6)N5C

InChI

InChIKey=RMMXLENWKUUMAY-UHFFFAOYSA-N
InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)

HIDE SMILES / InChI
Molecular Formula C33H30N4O2
Molecular Weight 514.6169
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:33:44 UTC 2023
Edited
by admin
on Fri Dec 15 15:33:44 UTC 2023
Record UNII
U5SYW473RQ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TELMISARTAN
EMA EPAR   EP   HSDB   INN   JAN   MART.   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD  
INN   USAN  
Official Name English
TELMISARTAN COMPONENT OF MICARDISPLUS
Brand Name English
BIBR 277 SE
Code English
TELMISARTAN [EMA EPAR]
Common Name English
KINZALMONO
Brand Name English
TELMISARTAN [EP IMPURITY]
Common Name English
BIBR-277
Code English
TELMISARTAN [GREEN BOOK]
Common Name English
TELMISARTAN [USP MONOGRAPH]
Common Name English
TELMISARTAN COMPONENT OF ONDUARP
Brand Name English
TELMISARTAN [USP-RS]
Common Name English
TELMISARTAN [MART.]
Common Name English
TOLURA
Brand Name English
TELMISARTAN [JAN]
Common Name English
TELMISARTAN TEVA
Brand Name English
KINZALKOMB COMPONENT TELMISARTAN
Brand Name English
TELMISARTAN [EMA EPAR VETERINARY]
Common Name English
MICARDISPLUS COMPONENT TELMISARTAN
Brand Name English
BIBR-277 SE
Code English
TELMISARTAN COMPONENT OF KINZALKOMB
Brand Name English
PRITORPLUS COMPONENT TELMISARTAN
Brand Name English
(1,1'-BIPHENYL)-2-CARBOXYLIC ACID, 4'-((1,4'-DIMETHYL-2'-PROPYL(2,6'-BI-1H-BENZIMIDAZOL)-1'-YL)METHYL)-
Common Name English
TELMISARTAN COMPONENT OF TOLUCOMBI
Brand Name English
TELMISARTAN [USAN]
Common Name English
TWYNSTA COMPONENT TELMISARTAN
Common Name English
ONDUARP COMPONENT TELMISARTAN
Brand Name English
telmisartan [INN]
Common Name English
MICARDIS HCT COMPONENT TELMISARTAN
Common Name English
TELMISARTAN COMPONENT OF MICARDIPLUS
Brand Name English
C09CA07
Code English
TELMISARTAN [EP MONOGRAPH]
Common Name English
PRITOR
Brand Name English
TELMISARTAN [MI]
Common Name English
Telmisartan [WHO-DD]
Common Name English
MICARDIS
Brand Name English
TELMISARTAN [VANDF]
Common Name English
TELMISARTAN COMPONENT OF TWYNSTA
Common Name English
BIBR-277-SE
Code English
TELMISARTAN COMPONENT OF PRITORPLUS
Brand Name English
TELMISARTAN TEVA PHARMA
Brand Name English
SEMINTRA
Brand Name English
TELMISARTAN [ORANGE BOOK]
Common Name English
TELMISARTAN [HSDB]
Common Name English
TOLUCOMBI COMPONENT TELMISARTAN
Brand Name English
TELMISARTAN ACTAVIS
Brand Name English
4'-((4-METHYL-6-(1-METHYL-2-BENZIMIDAZOLYL)-2-PROPYL-1-BENZIMIDAZOLYL)METHYL)-2-BIPHENYLCARBOXYLIC ACID
Systematic Name English
Classification Tree Code System Code
LIVERTOX NBK548042
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
EMA ASSESSMENT REPORTS TELMISARTAN ACTAVIS (AUTHORIZED: HYPERTENSION)
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
WHO-VATC QC09DA07
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
EMA ASSESSMENT REPORTS KINZALKOMB (AUTHORIZED: HYPERTENSION)
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
NCI_THESAURUS C66930
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
EMA ASSESSMENT REPORTS TOLURA (AUTHORIZED: HYPERTENSION)
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
WHO-ATC C09DB04
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
WHO-VATC QC09DB04
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
EMA VETERINARY ASSESSMENT REPORTS SEMINTRA [AUTHORIZED]
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
EMA ASSESSMENT REPORTS TOLUCOMBI (AUTHORIZED: HYPERTENSION)
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
WHO-VATC QC09CA07
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
EMA ASSESSMENT REPORTS ONDUARP (WITHDRAWN: HYPERTENSION)
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
WHO-ATC C09CA07
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
WHO-ATC C09DA07
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
EMA ASSESSMENT REPORTS PRITOR (AUTHORIZED: HYPERTENSION)
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
EMA ASSESSMENT REPORTS KINZALMONO (AUTHORIZED: HYPERTENSION)
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
EMA ASSESSMENT REPORTS TELMISARTAN TEVA PHARMA (AUTHORIZED: HYPERTENSION)
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
NDF-RT N0000175561
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
EMA ASSESSMENT REPORTS TELMISARTAN TEVA (AUTHORIZED: HYPERTENSION)
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
EMA ASSESSMENT REPORTS TWYNSTA (AUTHORIZED: HYPERTENSION)
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
EMA ASSESSMENT REPORTS MICARDISPLUS (AUTHORIZED: HYPERTENSION)
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
NDF-RT N0000000070
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
EMA ASSESSMENT REPORTS MICARDIS (AUTHORIZED: HYPERTENSION)
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
EMA ASSESSMENT REPORTS PRITORPLUS (AUTHORIZED: HYPERTENSION)
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
Code System Code Type Description
MESH
C084178
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
WIKIPEDIA
TELMISARTAN
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
LACTMED
Telmisartan
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
USAN
II-75
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
DAILYMED
U5SYW473RQ
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
IUPHAR
592
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
RS_ITEM_NUM
1643419
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
SMS_ID
100000089190
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
MERCK INDEX
m10541
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY Merck Index
ChEMBL
CHEMBL1017
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
DRUG CENTRAL
2583
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
PUBCHEM
65999
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
DRUG BANK
DB00966
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
CAS
144701-48-4
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
RXCUI
73494
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY RxNorm
CHEBI
9434
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
FDA UNII
U5SYW473RQ
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
EVMPD
SUB10874MIG
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
EPA CompTox
DTXSID8023636
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
NCI_THESAURUS
C47746
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
HSDB
7590
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
INN
7144
Created by admin on Fri Dec 15 15:33:45 UTC 2023 , Edited by admin on Fri Dec 15 15:33:45 UTC 2023
PRIMARY
Related Record Type Details
OAT-3
TRANSPORTER -> INHIBITOR
PLASMA PROTEIN FRACTION (HUMAN)
BINDER->LIGAND
BINDING
OATL-4
TRANSPORTER -> INHIBITOR
TYPE-1 ANGIOTENSIN II RECEPTOR
TARGET -> INHIBITOR
OAT-4
TRANSPORTER -> INHIBITOR
OAT-1
TRANSPORTER -> INHIBITOR
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA
TARGET -> AGONIST
SELECTIVE
OATP1B1
TRANSPORTER -> INHIBITOR
Related Record Type Details
Structure of TELMISARTAN GLUCURONIDE
METABOLITE INACTIVE -> PARENT
Structure of TELMISARTAN GLUCURONIDE
METABOLITE INACTIVE -> PARENT
only metabolite that has been identified in human plasma and urine
Related Record Type Details
Structure of TELMISARTAN METHYL ESTER
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of N-NITROSODIETHYLAMINE
IMPURITY -> PARENT
Probable human carcinogen.
Structure of 4'-((7-METHYL-5-(1-METHYL-1H-BENZIMIDAZOL-2-YL)-2-PROPYL-1H-BENZIMIDAZOL-1-YL)METHYL)BIPHENYL-2-CARBOXYLIC ACID
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of 4-METHYL-6-(1-METHYL-1H-BENZIMIDAZOL-2-YL)-2-PROPYL-1H-BENZIMIDAZOLE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of TELMISARTAN TERT-BUTYL ESTER
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
Ph.Eur.; USP
Structure of 4-((5-CHLORO-1,7-DIMETHYL-2-PROPYL-1H,3H-(2,5-BIBENZIMIDAZOL)-3-YL)METHYL)(1,1-BIPHENYL)-2-CARBOXYLIC ACID.
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 4-METHYL-6-(1-METHYL-1H-BENZIMIDAZOL-2-YL)-2-PROPYL-1H-BENZIMIDAZOLE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of N-NITROSODIMETHYLAMINE
IMPURITY GENOTOXIC->PARENT
NDMA is an organic chemical that is in a family of potent carcinogens.
Structure of TELMISARTAN AMIDE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
Ph.Eur.; USP
Structure of TERT-BUTYL 4'-(BROMOMETHYL)BIPHENYL-2-CARBOXYLATE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 6-DES(1-METHYL-2-BENZIMIDAZOLYL)-6-CARBOXY TELMISARTAN
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 2-DESCARBOXY-2-CYANO TELMISARTAN
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of BENZYL(METHYL)NITROSAMINE
IMPURITY -> PARENT
Priority toxic pollutant.
Structure of 4'-((7-METHYL-5-(1-METHYL-1H-BENZIMIDAZOL-2-YL)-2-PROPYL-1H-BENZIMIDAZOL-1-YL)METHYL)BIPHENYL-2-CARBOXYLIC ACID
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
Structure of TELMISARTAN
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966